Kraig Biocraft Laboratories, Inc. was pleased to announce this morning that during the months of May, June and July the scientific team achieved its previously announced goal to significantly ramp up the number of genetic insertions performed. The team’s initial goal was to double the number of DNA construct insertions performed in May. However, the actual number of insertions performed greatly exceeded that goal and the increase was sustained in June and July as well.

“Over the last ninety days, Dr. Fraser’s team has performed tens of thousands of DNA construct insertions. This increase in laboratory productivity greatly exceeded management’s expectations for the period,” stated CEO Kim K. Thompson. “This dramatic increase in productivity is an indication of the dedication and enthusiasm of the scientists. We know that each insertion has the potential to create a new recombinant fiber with commercial applications.”

Let us hear your thoughts: Kraig Biocraft Laboratories, Inc. Message Board

Last 5 posts by QualityStocks

• Some Options as the US Dollar Continues its Slide - November 24th, 2009
• Newport Digital Technologies (NPDT.OB) Has a Competitive Edge - November 24th, 2009
• Small Cap Voice Featured Company: DecisionPoint Systems, Inc. (DNPI.OB) - November 24th, 2009
• Small Cap Voice Featured Company: Hitor Group, Inc. (HITR.OB) - November 24th, 2009
• Novavax, Inc. (NVAX) Prices Offering Of Common Stock - November 24th, 2009